Curcumin prevents chronic intermittent hypoxia-induced myocardial injury.

curcumin intermittent hypoxia myocardial injury

Journal

Therapeutic advances in chronic disease
ISSN: 2040-6223
Titre abrégé: Ther Adv Chronic Dis
Pays: United States
ID NLM: 101532140

Informations de publication

Date de publication:
2020
Historique:
received: 12 10 2019
accepted: 24 03 2020
entrez: 9 7 2020
pubmed: 9 7 2020
medline: 9 7 2020
Statut: epublish

Résumé

Chronic intermittent hypoxia (IH), the hallmark feature of obstructive sleep apnoea syndrome, contributes to infarct size enhancement after myocardial ischemia-reperfusion (I/R). Curcumin (Curc), the natural pigment of Swiss/SV129 mice were exposed to normoxia or IH (21-5% FiO IH increased nuclear HIF-1α expression and superoxide anion (O Curc prevents IH-induced myocardial cell death signalling. Curc might be used as a combined therapy with continuous positive airway pressure in sleep apnoea patients with high cardiovascular risk.

Sections du résumé

BACKGROUND BACKGROUND
Chronic intermittent hypoxia (IH), the hallmark feature of obstructive sleep apnoea syndrome, contributes to infarct size enhancement after myocardial ischemia-reperfusion (I/R). Curcumin (Curc), the natural pigment of
METHODS METHODS
Swiss/SV129 mice were exposed to normoxia or IH (21-5% FiO
RESULTS RESULTS
IH increased nuclear HIF-1α expression and superoxide anion (O
CONCLUSION CONCLUSIONS
Curc prevents IH-induced myocardial cell death signalling. Curc might be used as a combined therapy with continuous positive airway pressure in sleep apnoea patients with high cardiovascular risk.

Identifiants

pubmed: 32637058
doi: 10.1177/2040622320922104
pii: 10.1177_2040622320922104
pmc: PMC7315663
doi:

Types de publication

Journal Article

Langues

eng

Pagination

2040622320922104

Informations de copyright

© The Author(s), 2020.

Déclaration de conflit d'intérêts

Conflict of interest statement: The authors declare that there is no conflict of interest.

Références

Metabolism. 2016 Aug;65(8):1124-35
pubmed: 27324067
Sleep. 2013 Apr 01;36(4):481-92
pubmed: 23564995
Am J Respir Crit Care Med. 2011 Sep 15;184(6):724-31
pubmed: 21680945
JCI Insight. 2017 Sep 7;2(17):
pubmed: 28878129
Biomed Pharmacother. 2017 Jan;85:102-112
pubmed: 27930973
Lancet Respir Med. 2019 Aug;7(8):687-698
pubmed: 31300334
Nat Rev Dis Primers. 2019 Jun 6;5(1):39
pubmed: 31171787
Can J Cardiol. 2020 Jun;36(6):936-940
pubmed: 32387037
Shock. 2014 Apr;41(4):346-54
pubmed: 24365880
Eur J Med Chem. 2019 Dec 1;183:111658
pubmed: 31514063
Eur Heart J. 2014 Jan;35(3):192-9
pubmed: 24164862
Heart. 2016 Mar;102(5):341-8
pubmed: 26674987
Int J Nanomedicine. 2019 Nov 18;14:8961-8972
pubmed: 31819412
Acta Med Indones. 2008 Oct;40(4):201-10
pubmed: 19151449
Sleep Med Rev. 2003 Feb;7(1):35-51
pubmed: 12586529
Basic Res Cardiol. 2012 May;107(3):263
pubmed: 22466958
Chest. 2017 Jan;151(1):225-241
pubmed: 27693594
Biomed Res Int. 2017;2017:2418671
pubmed: 28546962
J Am Coll Cardiol. 2009 Apr 14;53(15):1309-17
pubmed: 19358946
Molecules. 2019 Aug 01;24(15):
pubmed: 31374848
PLoS One. 2014 Apr 09;9(4):e94545
pubmed: 24718591
Tex Heart Inst J. 2018 Jun 1;45(3):151-161
pubmed: 30072851
Am J Respir Crit Care Med. 2019 Sep 1;200(5):551-555
pubmed: 30875238
Physiology (Bethesda). 2009 Apr;24:97-106
pubmed: 19364912
Sleep Breath. 2016 Sep;20(3):1069-74
pubmed: 26993339
Eur Respir Rev. 2019 Jun 26;28(152):
pubmed: 31243096
Sleep Breath. 2012 Mar;16(1):217-21
pubmed: 21331508
Am J Cardiol. 2012 Jul 1;110(1):40-4
pubmed: 22481014
Chest. 2005 Nov;128(5):3407-12
pubmed: 16304292
Can J Cardiol. 2015 Jul;31(7):909-17
pubmed: 26112301
J Appl Physiol (1985). 2016 Feb 15;120(4):437-43
pubmed: 26679613
Br J Pharmacol. 2012 Dec;167(7):1550-62
pubmed: 22823335
Molecules. 2016 Feb 25;21(3):264
pubmed: 26927041
Circulation. 2017 Nov 7;136(19):1840-1850
pubmed: 29109195
Phytother Res. 2019 May;33(5):1302-1317
pubmed: 30834628
Fundam Clin Pharmacol. 2013 Jun;27(3):252-61
pubmed: 22145601
Nat Rev Dis Primers. 2015 Jun 25;1:15015
pubmed: 27188535
Br J Pharmacol. 2017 Jun;174(11):1325-1348
pubmed: 27638428
Pharmacol Res. 2018 Nov;137:159-169
pubmed: 30315965
Respir Physiol Neurobiol. 2018 Sep;255:50-57
pubmed: 29758366
Int J Cardiol. 2016 May 1;210:45-53
pubmed: 26922713
Free Radic Biol Med. 2013 Dec;65:667-679
pubmed: 23880291
Antioxidants (Basel). 2019 Oct 22;8(10):
pubmed: 31652638
Free Radic Res. 2011 Oct;45(10):1223-31
pubmed: 21781008
Am J Physiol Heart Circ Physiol. 2016 Jan 15;310(2):H279-89
pubmed: 26566725
Exp Biol Med (Maywood). 2013 Feb;238(2):223-32
pubmed: 23404941
Pharm Biol. 2017 Dec;55(1):1144-1148
pubmed: 28224816
Pharmacol Ther. 2016 Dec;168:1-11
pubmed: 27492897

Auteurs

Sophie Moulin (S)

Université Grenoble Alpes-HP2-Grenoble F-38042, France / INSERM, U1042-Grenoble F38042, France.

Claire Arnaud (C)

Université Grenoble Alpes-HP2-Grenoble F-38042, France / INSERM, U1042-Grenoble F38042, France.

Sophie Bouyon (S)

Université Grenoble Alpes-HP2-Grenoble F-38042, France / INSERM, U1042-Grenoble F38042, France.

Jean-Louis Pépin (JL)

Université Grenoble Alpes-HP2-Grenoble F-38042, France / INSERM, U1042-Grenoble F38042, France / Centre Hospitalier Universitaire des Alpes, Grenoble F38042, France.

Diane Godin-Ribuot (D)

Université Grenoble Alpes-HP2-Grenoble F-38042, France / INSERM, U1042-Grenoble F38042, France.

Elise Belaidi (E)

University Grenoble Alpes, Grenoble, France INSERM, U1042, Grenoble, France.

Classifications MeSH